EGR1 and prostate carcinoma: The tumorigenic role of EGR-1 has been first revealed in prostate cancer, where high expression of EGR1 triggered cell proliferation and metastasis, leaving EGR1 as a candidate target for the therapy of prostate cancer [8,9].